PMID- 33781199 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20210402 IS - 1542-6416 (Print) IS - 1559-0275 (Electronic) IS - 1542-6416 (Linking) VI - 18 IP - 1 DP - 2021 Mar 30 TI - The associations between red cell distribution width and plasma proteins in a general population. PG - 12 LID - 10.1186/s12014-021-09319-9 [doi] LID - 12 AB - BACKGROUND: High red cell distribution width (RDW) has been increasingly recognized as a risk factor for cardiovascular diseases (CVDs), but the underlying mechanisms remain unknown. Our aim was to explore the associations between RDW and plasma proteins implicated in the pathogenesis of CVD using a targeted proteomics panel. METHODS: RDW and 88 plasma proteins were measured in a population-based cohort study (n = 4726), Malmo Diet and Cancer-Cardiovascular Cohort (MDC-CC). A random 2/3 of the cohort was used as discovery sample and remaining 1/3 was used for replication. Multiple linear regression was used to assess the associations between RDW and plasma proteins, with adjustments for age, sex, and other potential confounders. Proteins with Bonferroni-corrected significant associations with RDW in the discovery sub-cohort were validated in the replication cohort. RESULTS: Thirteen of 88 plasma proteins had significant associations with RDW in the discovery sample, after multivariate adjustments. Eleven of them were also significant in the replication sample, including SIR2-like protein 2 (SIRT2), stem cell factor (SCF, inversely), melusin (ITGB1BP2), growth differentiation factor-15 (GDF-15), matrix metalloproteinase-7 (MMP-7), hepatocyte growth factor (HGF), chitinase-3-like protein 1 (CHI3L1), interleukin-8 (IL-8), CD40 ligand (CD40-L), urokinase plasminogen activator surface receptor (U-PAR) and matrix metalloproteinase-3 (MMP-3). CONCLUSIONS: Several proteins from this targeted proteomics panel were associated with RDW in this cohort. These proteins could potentially be linked to the increased cardiovascular risk in individuals with high RDW. FAU - Pan, Jingxue AU - Pan J AUID- ORCID: 0000-0002-2231-2668 AD - Department of Clinical Sciences, Lund University, CRC Hus 60 plan 13, Jan Waldenstroms gata 35, 20502, Malmo, Sweden. jingxue.pan@med.lu.se. FAU - Borne, Yan AU - Borne Y AD - Department of Clinical Sciences, Lund University, CRC Hus 60 plan 13, Jan Waldenstroms gata 35, 20502, Malmo, Sweden. FAU - Orho-Melander, Marju AU - Orho-Melander M AD - Department of Clinical Sciences, Lund University, CRC Hus 60 plan 13, Jan Waldenstroms gata 35, 20502, Malmo, Sweden. FAU - Nilsson, Jan AU - Nilsson J AD - Department of Clinical Sciences, Lund University, CRC Hus 60 plan 13, Jan Waldenstroms gata 35, 20502, Malmo, Sweden. FAU - Melander, Olle AU - Melander O AD - Department of Clinical Sciences, Lund University, CRC Hus 60 plan 13, Jan Waldenstroms gata 35, 20502, Malmo, Sweden. FAU - Engstrom, Gunnar AU - Engstrom G AD - Department of Clinical Sciences, Lund University, CRC Hus 60 plan 13, Jan Waldenstroms gata 35, 20502, Malmo, Sweden. LA - eng GR - 2016-0315/Hjart-Lungfonden (SE)/ GR - 2017-0626/Hjart-Lungfonden/ GR - 201806230280/China Scholarship Council/ PT - Journal Article DEP - 20210330 PL - England TA - Clin Proteomics JT - Clinical proteomics JID - 101184586 PMC - PMC8008679 OTO - NOTNLM OT - Cardiovascular panel OT - Plasma proteomics OT - Population-based OT - Red cell distribution width COIS- The authors declare that they have no competing conflicts of interests. EDAT- 2021/03/31 06:00 MHDA- 2021/03/31 06:01 PMCR- 2021/03/30 CRDT- 2021/03/30 05:51 PHST- 2020/02/21 00:00 [received] PHST- 2021/03/12 00:00 [accepted] PHST- 2021/03/30 05:51 [entrez] PHST- 2021/03/31 06:00 [pubmed] PHST- 2021/03/31 06:01 [medline] PHST- 2021/03/30 00:00 [pmc-release] AID - 10.1186/s12014-021-09319-9 [pii] AID - 9319 [pii] AID - 10.1186/s12014-021-09319-9 [doi] PST - epublish SO - Clin Proteomics. 2021 Mar 30;18(1):12. doi: 10.1186/s12014-021-09319-9.